Intravesical drug delivery devices and methods including elastic polymer-drug matrix systems

Patent metadata

Field	Value
Publication number	US-12239807-B2
Application number	US-202016989208-A
Country	US
Kind code	B2
Filing date	Aug 10, 2020
Priority date	Jun 26, 2014
Publication date	Mar 4, 2025
Grant date	Mar 4, 2025

Abstract

Intravesical drug delivery devices are provided which may include an elongated body formed of a matrix system of a drug dispersed in a silicone, wherein the elongated body has a first end, an opposed second end, and an intermediate portion between the first and second ends, and wherein the silicone of the matrix system is cured to bias the elongated body in a coiled retention shape, such that the device is elastically deformable between a relatively straightened shape suited for insertion of the device through a urethra and into the urinary bladder of a patient and the coiled retention shape which is suited to retain the device within the urinary bladder.

First claim

We claim:

1. An intravesical drug delivery device comprising:
an elongated body formed of a matrix system of a drug dispersed in a silicone, the elongated body having a first end, an opposed second end, and an intermediate portion between the first and second ends; and
an elastic retention frame associated with the elongated body and effective to bias the elongated body into a coiled retention shape,
wherein the elastic retention frame is disposed within a lumen sealed at its ends and defined by an annular tube which is located within the matrix system, the lumen extending in a direction from the first end to the second end.

2. The device of claim 1 , wherein the elastic retention frame comprises a nitinol wire or other superelastic wire.

3. The device of claim 1 , further comprising an outer wall layer that covers at least the intermediate portion, wherein the outer wall layer comprises a water- and drug-permeable polymeric material.

4. The device of claim 1 , wherein the silicone is a high durometer silicone.

5. The device of claim 1 , wherein the drug comprises from 1 wt % to 20 wt % of the matrix system.

6. A method of administering a drug to a patient in need thereof, comprising:
inserting into the patient the intravesical device of claim 1 , by passing the device through the patient's urethra and into the patient's urinary bladder; and
releasing the drug from the device to a tissue site within the patient.

7. An intravesical drug delivery device comprising:
an elongated body formed of a matrix system of a drug dispersed in a silicone, the elongated body having a first end, an opposed second end, and an intermediate portion between the first and second ends;
an elastic retention frame associated with the elongated body and effective to bias the elongated body into a coiled retention shape; and
an outer wall layer that covers at least the intermediate portion, wherein the outer wall layer comprises a water- and drug-permeable polymeric material,
wherein the elastic retention frame comprises a nitinol wire or other superelastic wire,
wherein the nitinol wire or other superelastic wire is disposed within a lumen which is adjacent to the elongated body, the lumen extending in a direction from the first end to the second end and being defined by an annular tube which is formed of the water- and drug-permeable polymeric material.

8. An intravesical drug delivery device comprising:
an elongated body formed of a matrix system of a drug dispersed in a biocompatible polymer, the elongated body having a first end, an opposed second end, and an intermediate portion between the first and second ends; and
an elastic retention frame associated with the elongated body and effective to bias the elongated body into a coiled retention shape,
wherein the matrix system extends from the first end to the second end, and
wherein the elastic retention frame is disposed within a lumen sealed at its ends and defined by an annular tube which is located within the matrix system, the lumen extending in a direction from the first end to the second end.

9. The device of claim 8 , wherein the biocompatible polymer comprises a polyurethane.

10. An intravesical drug delivery device comprising:
an elongated body formed of a matrix system of a drug dispersed in a non-bioerodible, biocompatible polymer, the elongated body having a first end and an opposed second end wherein the matrix system extends continuously between the first end and the second end,
wherein the polymer of the matrix system biases the device in a retention shape, such that the device is elastically deformable between a relatively straightened shape suited for insertion of the device through the urethra and into the urinary bladder of a patient and the retention shape which is suited to retain the device within the urinary bladder.

11. The intravesical drug delivery device of claim 10 , wherein the biocompatible polymer comprises a silicone or a polyurethane.

12. The intravesical drug delivery device of claim 10 , wherein the drug is present in the matrix system in an amount from 1% to 20% by weight.

13. The intravesical drug delivery device of claim 10 , wherein the retention shape is coiled and the elongated body is from 10 cm to 15 cm in length.

14. The intravesical drug delivery device of claim 10 , wherein the polymer of the matrix system has a durometer value from 45 Shore A to 88 Shore A.

Assignees

• Taris Biomedical Llc

Inventors

• Lee Heejin
• Daniel Karen

Classifications

• A61M2210/1085

  Bladder · CPC title

• A61M2207/00

  Methods of manufacture, assembly or production · CPC title

• A61M2205/0216

  Materials providing elastic properties, e.g. for facilitating deformation and avoid breaking · CPC title

• A61M25/0009

  Making of catheters or other medical or surgical tubes · CPC title

• A61K9/0034 Primary

  Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants · CPC title